Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
13
Bearish filings
33
Named actors
18
Disclosed $ (bull / bear)
$69.2M / $1.0B
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-26 | EVP & Chief Legal & Admin Off. McAlevey Michael R | disposed of shares (non-open-market) | $3.3M | SEC ↗ |
| 2026-06-30 | Institution (13F) VIKING GLOBAL INVESTORS LP | exited a position | $508.8M | — |
| 2026-06-17 | Congress Jared Moskowitz | bought | $8K | — |
| 2026-05-07 | EVP and CFO Marks Mike A | gifted | — | SEC ↗ |
| 2026-04-30 | 5%+ holder (13G) VANGUARD CAPITAL MANAGEMENT LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-03-31 |
21 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| added to a position |
| $42.3M |
| — |
| 2026-03-31 | Institution (13F) Abdiel Capital Advisors, LP | added to a position | $4.2M | — |
| 2026-03-27 | Congress Alan Armstrong | bought | $8K | — |
| 2026-02-18 | EVP & Chief Legal & Admin Off. McAlevey Michael R | sold | $904K | SEC ↗ |
| 2026-02-18 | OFFICER (via Merrill Lynch) Michael R McAlevey | filed notice to sell | $903K | SEC ↗ |
| 2026-02-13 | EVP & Chief Legal & Admin Off. McAlevey Michael R | exercised options & held the shares | $1.2M | — |
| 2026-02-11 | SVP & Chief Human Res. Officer Berres Jennifer | sold | $2.0M | SEC ↗ |
| 2026-02-11 | SVP & Chief Human Res. Officer Berres Jennifer | sold | $2.1M | SEC ↗ |
| 2026-02-11 | SVP & Controller Wyatt Christopher F. | sold | $2.0M | SEC ↗ |
| 2026-02-11 | OFFICER (via Merrill Lynch) Jennifer L. Berres | filed notice to sell | $4.1M | SEC ↗ |
| 2026-02-10 | Activist (13D) Frisco Holding II | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-02-05 | EVP and COO Foster Jon M | exercised options & held the shares | $4.1M | — |
| 2026-02-05 | SVP & Controller Wyatt Christopher F. | exercised options & held the shares | $1.5M | — |
| 2026-02-04 | CEO HAZEN SAMUEL N | disposed of shares (non-open-market) | $521K | SEC ↗ |
| 2026-02-03 | EVP and Chief Clinical Officer Cuffe Michael S. | sold | $747K | SEC ↗ |
| 2026-02-03 | EVP and Chief Clinical Officer Cuffe Michael S. | gifted | — | SEC ↗ |
| 2026-02-03 | CEO HAZEN SAMUEL N | sold | $3.1M | SEC ↗ |
| 2026-02-03 | CEO HAZEN SAMUEL N | sold | $7.4M | SEC ↗ |
| 2026-02-03 | CEO HAZEN SAMUEL N | sold | $2.5M | SEC ↗ |
| 2026-02-03 | CEO HAZEN SAMUEL N | sold | $3.7M | SEC ↗ |